Cytologic diagnosis of lobular carcinoma of the breast. Experience with 555 patients in the Rene Huguenin Cancer center

Department of Pathology, René Huguenin Center, St. Cloud, France.
Cancer (Impact Factor: 4.89). 05/2008; 114(2):111-7. DOI: 10.1002/cncr.23347
Source: PubMed


Fine-needle aspiration generally produces results that are not as good for lobular carcinoma as the results for ductal carcinoma of the breast. In this study, the authors evaluated their team's performance in cytologic diagnosis of lobular carcinoma over 11 years and analyzed the reasons for diagnostic failure.
Cytologic findings were analyzed in 555 consecutive fine-needle cytopuncture specimens from women with palpable, invasive lobular carcinoma of the breast. The authors also examined the influence of the cytologist's experience, the clinical tumor size, the histologic subtype, and the histologic grade on diagnostic performance. All negative samples were re-examined, along with all samples that had been obtained during the last year of the study, to refine the morphologic description of lobular carcinoma.
Malignancy was diagnosed in 68.8% of specimens overall. The individual pathologists diagnosed malignancy in from 44.4% to 81.1% of specimens, depending on their experience. Diagnostic performance was correlated with clinical tumor size, histologic grade, and histologic subtype, and correct diagnoses were significantly more frequent in pleomorphic subtypes than in "classic" types. Re-examination of all 32 negative specimens reduced the false-negative rate from 5.8% to 3.8%.
Despite the pitfalls associated with lobular carcinoma of the breast, fine-needle cytopuncture remains a useful diagnostic tool before treatment. Failures can be reduced through experience and by better knowledge of cytologic features.

Full-text preview

Available from:
  • Source

    Full-text · Article · May 2008 · Expert Review of Endocrinology & Metabolism
  • [Show abstract] [Hide abstract]
    ABSTRACT: To describe the cytological appearances of melanoma in fluid specimens and potential diagnostic pitfalls in interpreting such specimens, which have been infrequently reported in the literature. Cases of melanoma diagnosed at a single institution between 1993 and 2008 in cytology specimens of fluids (pleural, ascitic, cerebrospinal and other fluids), but excluding fine needle biopsy specimens, were identified and reviewed. 32 fluid specimens containing metastatic melanoma (from 26 patients) were identified. Most of the specimens were moderately cellular and showed moderate to marked nuclear pleomorphism. Mitotic figures and intranuclear cytoplasmic invaginations were identified in 11 (34.4%) and seven (21.9%) cases, respectively. Melanin pigment was seen in eight (25.0%) cases. Variable numbers of histiocytes were present, and mesothelial cells were present in body cavity fluid specimens. In fluid specimens, reactive mesothelial cells and histiocytes may mimic epithelioid melanoma cells. Awareness of the morphological features and diagnostic pitfalls of melanoma in fluids is necessary to avoid the potentially serious consequences of misdiagnosis.
    No preview · Article · Aug 2009 · Journal of clinical pathology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and aim: Breast cancer is the second most common malignancy in Korean women. Fine needle aspiration cytology (FNAC) has been used as the first-line pathological modality; however, use of core needle biopsy (CNB) is on the increase. FNAC is a cost effective, less invasive and rapid method for evaluation of breast lesions. The limitations of FNAC, such as high false negative rates and equivocal results restrict its use. The aim of this study is to evaluate FNAC as a diagnostic tool in comparison with CNB by matching corresponding excision specimens. Methods: From May, 2003 to April, 2008, 753 cases of FNAC, 331 cases of CNB, and 98 cases of combined FNAC and CNB were collected. Diagnoses with FNAC and CNB were compared with excision. Results: Sensitivity, specificity, and diagnostic accuracy of FNAC were 93.8%, 80.8%, and 90.1%, respectively. Those of CNB were 92.1%, 90.9%, and 92.3%, and combined FNAC and CNB, 100%, 77.8%, and 98.0%. There were no false positive cases in either the FNAC or the CNB group. False negative rates were 6.2% in FNAC and 9.9% in CNB. Sampling error was the cause of error or a false negative result in all FNAC samples, and all but one CNB sample. Diagnostic accuracy of FNAC was superior to that of CNB for lesions between 1 cm and 2 cm. Conclusions: Our data suggest that FNAC is an accurate and reliable first line diagnostic tool for evaluation of breast lesions when compared with core biopsy.
    No preview · Article · Feb 2010 · Basic and Applied Pathology
Show more